By Editor , 21 October 2026
WuXi Biologics Wins Top Jade Award at Asset ESG Awards 2026

Shanghai – October 21, 2026 -- WuXi Biologics (2269.HK) won the Jade Award, the highest distinction at The Asset Corporate Sustainability Leadership Awards 2026, and was the only pharmaceutical company among this year's Jade recipients. The contract research, development and manufacturing organization (CRDMO) also took the Best in Transition (Hong Kong) award.

By Editor , 13 October 2026

Hong Kong – October 13, 2026 -- Fosun International (HKEX: 00656) won five awards at The Asset Corporate Sustainability Leadership Awards 2026, moving up from Gold to the Platinum Award in the main category.

The Hong Kong-listed group also took four single-category prizes: Best in Disclosure & Transition, Best Initiative in Environmental Responsibility, Best Initiative in Social Responsibility and Best Sustainability Team. The Asset is an Asia-Pacific financial publication.